{"url_path":"/sec/mbx/8-k/2026-06-05/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1776111/0001193125-26-258417-index.html","accession_number":"0001193125-26-258417","cik":"0001776111","ticker":"MBX","issuer_name":"MBX Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1776111/0001193125-26-258417-index.html","primary_entity_key":"0001776111","primary_entity_name":"MBX Biosciences, Inc."},"word_count":75,"has_tables":true,"body_markdown":"## Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.\n\nOn June 4, 2026, MBX Biosciences, Inc. (the \"Company\") held its 2026 annual meeting of stockholders (the \"Annual Meeting\"). As further described under Item 5.07 below, the Company's stockholders approved the election of two Class II directors to serve for a three-year term ending at the annual meeting of stockholders to be held in 2029."}